Burroughs Amy L.
Transaction: 05/05/2026
SELL
Change
-300,000
Price
$37.18
Filing
05/05/2026
Type
SELL
Terns Pharmaceuticals, Inc.
TERN • Biotechnology
$52.95
— 0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.93B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 62.41Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$52.95
Change0.00%
Shares Out93.17M
Market Cap$4.93B
Enterprise Value$3.91B
52W Range2.65 - 53.19
Beta-0.38
P/E-51.28
P/B4.90
P/FCF-60.03
EV/EBITDA-35.54
EV/FCF-47.63
Price$52.95
Change0.00%
Shares Out93.17M
Market Cap$4.93B
Enterprise Value$3.91B
52W Range2.65 - 53.19
Beta-0.38
P/E-51.28
P/B4.90
P/FCF-60.03
EV/EBITDA-35.54
EV/FCF-47.63
Earnings Yield-1.95%
FCF Yield-1.67%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio62.41
Quick Ratio62.41
Target$51.40
Target Upside-2.93%
Target Median$56.00
Target Range14.00 - 70.00
Volume6.33M
Avg Volume5.92M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 62.41Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 16 analyst votes · 2026-10-20
81/100
Bullish
Bullish
10
Hold
6
Bearish
0
Price Target
2026-06-05
Low
$53.00
Mean
$58.13
Median
$57.00
High
$70.00
Insider Transactions
Recent executive and insider activity
⚠ 4 high-volume insider sells detected
Burroughs Amy L.
Transaction: 05/05/2026
SELL
Change
-150,000
Price
$53.00
Filing
05/05/2026
Type
SELL
Gengos Andrew
Transaction: 05/05/2026
SELL
Change
-137,500
Price
$37.18
Filing
05/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Burroughs Amy L. | SELL | -300,000 | $37.18 | 05/05/2026 | 05/05/2026 |
| Burroughs Amy L. | SELL | -150,000 | $53.00 | 05/05/2026 | 05/05/2026 |
| Gengos Andrew | SELL | -137,500 | $37.18 | 05/05/2026 | 05/05/2026 |
| Gengos Andrew | SELL | -68,750 | $53.00 | 05/05/2026 | 05/05/2026 |
| Kuriakose Emil | SELL | -112,500 | $37.18 | 05/05/2026 | 05/05/2026 |
| Kuriakose Emil | SELL | -81,953 | $53.00 | 05/05/2026 | 05/05/2026 |
| FELLOWS DAVID A | SELL | -2,828 | $34.60 | 05/05/2026 | 05/05/2026 |
| KINDLER JEFFREY B | SELL | -1,697 | $34.60 | 05/05/2026 | 05/05/2026 |
| Quigley Jill M. | SELL | -1,697 | $34.60 | 05/05/2026 | 05/05/2026 |
| Tripuraneni Radhika | SELL | -1,697 | $34.60 | 05/05/2026 | 05/05/2026 |
| Turner Heather D | SELL | -1,697 | $34.60 | 05/05/2026 | 05/05/2026 |
| Azelby Robert | SELL | -1,697 | $34.60 | 05/05/2026 | 05/05/2026 |
| Kuriakose Emil | SELL | -942 | $52.75 | 04/01/2026 | 04/02/2026 |
| Burroughs Amy L. | SELL | -2,770 | $47.30 | 03/16/2026 | 03/17/2026 |
| Burroughs Amy L. | SELL | -14,583 | $4.64 | 03/16/2026 | 03/17/2026 |
| Burroughs Amy L. | SELL | -4,083 | $39.80 | 02/17/2026 | 02/18/2026 |
| Burroughs Amy L. | SELL | -14,583 | $4.64 | 02/17/2026 | 02/18/2026 |
| FELLOWS DAVID A | BUY | +2,828 | $34.60 | 02/01/2026 | 02/02/2026 |
| KINDLER JEFFREY B | BUY | +1,697 | $34.60 | 02/01/2026 | 02/02/2026 |
| Quigley Jill M. | BUY | +1,697 | $34.60 | 02/01/2026 | 02/02/2026 |